Princeton, NJ – January 13, 2025 – KYBORA, a global healthcare advisory firm and investment bank, is proud to announce that Stefan Bluemmers, MD, MBA, has joined the company as Managing Director. With a proven track record of strategic leadership in the pharmaceutical and biotechnology sectors, Stefan will play a pivotal role in advancing KYBORA’s mission to guide transformative healthcare companies to enduring success globally.
Stefan brings more than 20 years of experience and a wealth of accomplishments, including:
At KYBORA, Stefan will focus on building strong client relationships, driving strategic transactions, and ensuring high-quality results that align with KYBORA’s purpose: guiding transformative healthcare companies to enduring success globally.
Alan Vanderborght, CEO of KYBORA, shared: “We are delighted to welcome Stefan to the KYBORA team. His remarkable expertise, innovative mindset, and commitment to excellence align perfectly with our values and strategic goals. Together, we are poised to continue helping transformative healthcare companies achieve lasting success.”
Stefan Bluemmers also shared his excitement about joining the team: “I first got to know KYBORA as a client. The expertise and experience were impressive but what made it an extraordinary experience was the strategic mindset and advise I received – going far beyond the transactional. I couldn’t be more excited to join this Team!”
KYBORA remains committed to its core values:
Stay connected with KYBORA as we continue to empower the healthcare industry and drive enduring success globally. Visit us at www.kybora.com to learn more about our mission and services.
About KYBORA:
KYBORA is a global advisory firm and investment bank specializing in delivering strategic M&A, licensing, fundraising, and consulting solutions to the biopharma sector. Guided by a commitment to innovation and excellence, KYBORA partners with healthcare companies to unlock growth opportunities and achieve long-term value creation.